Abstract While methamphetamine-induced changes in brain neurotransmitters, their receptors, and transporters are well studied, the means by which methamphetamine abuse results in cognitive and behavioral abnormalities is unknown. Here, we administered methamphetamine chronically, in doses relevant to recreational usage patterns, to nonhuman primates. Neurostructural analysis revealed decreased dendritic material and loss of spines in frontal lobe neurons. Molecular examination demonstrated that type I interferons (interferon-alpha and interferon-beta) increased in the frontal lobe in response to chronic methamphetamine treatment, in correlation with the neuronal changes. Chronic methamphetamine thus results in significant changes in the primate brain, inducing cytokines and altering neuronal structure, both of which can contribute to functional abnormalities.
Introduction
D-Methamphetamine hydrochloride (methamphetamine, METH) is a strong central nervous system (CNS) stimulant. METH is similar in structure to dopamine and is closely related to two similar stimulants, amphetamine and methylenedioxymethamphetamine. METH is a popular selection among the drug abusing population due to its price, availability, and psychological effects, which include feelings of euphoria, increased performance, and enhancement of sexual pleasure. METH is a substrate for the dopamine transporter (DAT), and thus gains access to dopamine (DA) system neurons, where it inhibits the vesicular monoamine transporter (VMAT2), leading to increased DA in the synaptic cleft (Volz et al. 2007 ).
Although a number of studies have examined the effects of METH on neurotransmitters and transporters, less information is available concerning other effects on neurons. Studies in young gerbils showed that METH induces morphological alteration of mesocortical dopamine nerve fibers and their postsynaptic structures in the frontal cortex (Wahnschaffe and Esslen 1985) , whereas in adult gerbils, an increase in dendritic spines was present in the prefrontal, but not parietal, cortex, and degrading axon terminals were found in layers III and V of the anterior cingulate (Dawirs et al. 1991) . Other experiments in METH-treated mice revealed shrinkage and degeneration of pyramidal cells in the frontal cortex and hippocampus (Kuczenski et al. 2007) .
Although a great amount has been learned from studies on METH in rodents, less information is available concerning its effects on humans. An autopsy study revealed that human chronic METH users had decreased levels of DA, DAT, and the dopamine synthetic enzyme tyrosine hydroxylase in the striatum (Wilson et al. 1996) , consistent with studies in rodents. Imaging studies have also revealed decreased DAT and VMAT2 as well as dopamine receptors in the striatum of living human METH abusers (Chang et al. 2007 ). Highresolution magnetic resonance imaging (MRI) has been used to examine the brains of chronic METH abusers. Gray matter cortical deficits were found, most significantly in the cingulate; smaller hippocampal volumes and a hypertrophy of the white matter were also present in METH abusers (Thompson et al. 2004 ). The exact mechanisms by which METH produces damage to the human CNS remain mostly hypothetical. Such mechanisms may involve toxic monoamine metabolites, glutamate-induced excitotoxic neurotoxicity, oxidative free-radical chemistry, and metabolic stress (Cadet et al. 2003) .
Nonhuman primates provide excellent animal models to study the effects of drugs of abuse on the brain. We have reported a METH dose escalation protocol in nonhuman primates, resulting in administration of levels of METH similar to that seen in recreational users, which results in both behavioral and physiological effects (Madden et al. 2005 . A similar dose escalation protocol was recently used in vervet monkeys revealing changes in striatal dopaminergic systems and behavior (Melega et al.2008 . Here, we used this protocol of chronic METH treatment on rhesus monkeys to first examine whether METH induced changes in neuronal structure, and second, to assess whether the chronic METH treatment produced changes in brain gene expression.
Methods

Animals
Rhesus monkeys were free of SIV, SRV-type D, STLV-I, and Cercopithecine herpesvirus 1. Three animals were treated with METH using our previously described dose escalation protocol (Madden et al. 2005) . Animals received the maintenance dose of METH (0.75 mg/kg/dose, twice a day Monday through Thursday, once on Friday, none on weekends) for 31-32 weeks before sacrifice per experimental protocol. Three untreated animals were used for the Golgi analysis and four for the gene expression analysis. At necropsy, performed after terminal anesthesia, animals were intracardially perfused with sterile PBS containing 1 U/ml heparin. Tissue samples for RNA isolation were frozen, and those for Golgi staining were immersion-fixed in 10% neutral buffered formalin. All animal experiments were performed with approval from the TSRI Institutional Animal Care and Use Committee following NIH guidelines.
Golgi analysis
Blocks were cut from the fixed tissue containing frontal cortex and caudate and stained using the rapid Golgi method. Briefly, blocks were impregnated with an osmium tetroxide and potassium dichromate mixture, followed by immersion in silver nitrate, then dehydrated and embedded in nitrocellulose; coronal sections were cut at 120 μm. For analysis, camera lucida drawings were made of the basilar dendritic tree of neurons in the indicated layer/structure using a ×40-long-working-distance oil-immersion lens, a ×1.6 intermediate lens, and a ×10 ocular viewer. For each control animal in each indicated area, nine neurons were randomly taken for examination, and in the METH-treated animals, eight neurons were randomly taken for examination. The extent and distribution of neuronal dendritic branching were evaluated by Sholl analysis, whereby a transparent overlay of increasingly larger concentric circles at 10 μm intervals is superimposed on the camera lucida drawings. The number of dendritic branch intersections with each progressively larger circle is counted from the soma of each neuron. The spines were also analyzed. Visible flanking spines were counted along 30 μm terminal-tip segments of four total segments for each neuron at a magnification of ×1,200.
Quantitative real-time polymerase chain reaction (PCR) RNA was isolated from frontal lobe and caudate samples, taken following necropsy, using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), and then further purified utilizing the RNeasy mini kit (Qiagen, Valencia, CA, USA). cDNA was synthesized and real-time PCR performed using duallabeled hydrolysis probes as described (Marcondes et al. 2007) . Sequences for the IFNα primers were GATGATC CAGCAGACCTTCA and TAGGAGGGTCTCATCCCA AG and the probe TCTTCAGCACAAAGGACTCATC TGCTG; for IFNβ, the primers were CGCTCTGGCA CAACAGGTAGT and GAGCAATTTGGAGGAGA CACTTG and the probe AGGCGACACTGTTCCTG TTCTCA; and for IFNγ, the primers were GCAGATA ATGGAACTCTTTTCTTAGACA and AGGAGACAATTT GGCTCTGCAT and the probe TTTCTGTCACTCTC CTCTTTCCAATTCCTCAA. The sequences of the control primers/probes were as described (Marcondes et al. 2007) ; the sequences for the other genes are available upon request. To compute the relative amounts of specific mRNA in the samples, the average cycle threshold (Ct) of the primary Fig. 1 Neurostructural analysis using Golgi staining in the anterior cingulate gyrus (ACG), middle frontal gyrus (MFG), and caudate nucleus. a Sholl analysis of dendrites. For each region, the number of dendritic intersections in concentric circles of the indicated distance from the soma was determined to assess the amount and distribution of dendritic material in control and METH-treated brains. The Wilcoxon signed-rank test was used to determine the p values. n.s. Not significant. b The number of spines in a 30-μm length on the terminal dendritic tips is indicated by box and whisker plots for each region in control and METH-treated animals. Student's t test revealed a significant (p= 0.0064) difference in the MFG, indicated by an asterisk b signals for the TATA-box binding protein, glyceraldehyde-3-phosphate dehydrogenase, and 18S ribosomal RNA (as controls) was subtracted from that of the specified genes to give the change in Ct (dCt), which are log 2 values.
Statistical analysis
Statistical analysis for the Sholl dendritic analysis was carried out with the Wilcoxon signed-rank test, for the spine analysis Student's unpaired t test, and for gene expression (using the log 2 dCt values) two-way ANOVA followed by Bonferroni post hoc tests, all using the Prism software (GraphPad Software, San Diego, CA, USA). For all tests, alpha was set at 0.05 to determine significance.
Results
In order to examine the effect of this chronic METH treatment protocol on the brain, we first performed a Golgi impregnation study on selected neuronal populations. Layer Fig. 2 Assessment of gene expression using quantitative real-time PCR. a Frontal lobe. Two-way ANOVA revealed increased expression of type I interferons in METH-treated animals compared to controls (p=0.0003), and Bonferroni post hoc test indicated both IFNα and IFNβ to be significantly increased (p<0.01 for both). b Caudate nucleus. Twoway ANOVA revealed that the increase in type I interferons did not reach statistical significance (p=0.0558). c Frontal lobe. Assessment of other genes: brain derived neurotropic factor (BNDF), cellular oncogene c-Fos (FOS), interleukin 1α (IL1α), interleukin 1β (IL1β), interleukin 6 (IL6), monocyte chemoattractant protein 1 (MCP-1) , regulator of Gprotein signaling 5 (RGS5), and tumor necrosis factor α (TNFα) revealed that although the control and METH groups differed by twoway ANOVA (p=0.0233), Bonferroni post hoc tests could not identify genes that significantly differed between the groups V neurons were examined in the two regions of the frontal lobe (anterior cingulate gyrus and middle frontal gyrus), and spiny neurons were examined in the caudate nucleus. The neurons were analyzed for dendritic branches and spines, allowing a structural examination of the functional parts of neurons. Sholl analysis was used to characterize the amount of dendritic material and its distribution. Significant loss of dendrites was found in the anterior cingulate and middle frontal gyri, but not in the caudate (Fig. 1a) . Examination of spines on the terminal dendritic tips revealed significant loss (17% less in the METH group) only in the middle frontal gyrus (Fig. 1b) . These data are consistent with METH-induced damage in the brain and reveal that frontal lobe neurons are targets of the direct or indirect actions of chronic METH administration.
In order to assess potential mediators of these neuronal changes, we examined the expression of interferons (IFN), since we had previously found that in METH using HIVinfected people compared to HIV-infected individuals who did not use METH, IFN-induced genes were elevated in the brain (Everall et al. 2005) . Indeed, the administration of METH in rhesus monkeys caused a significant change in IFN gene expression. Quantitative real-time PCR showed a significant upregulation of IFNα (12.6-fold) and IFNβ (16-fold) in the frontal lobe of the METH group (Fig. 2a) but not in the caudate (Fig. 2b) . No expression of IFNγ could be detected in either control or METH-administered animals. Levels of transcripts of a number of other genes were also assessed in the frontal lobe; however, no significant changes were found for the individual genes (Fig. 2c) .
Discussion
In the Golgi impregnation experiment, we found that METH administrations caused significant loss of dendrites in both areas of the frontal cortex examined: the anterior cingulate and middle frontal gyri, but not in the caudate. With further examination of spines on the terminal dendritic tips, we found significant loss only in the middle frontal gyrus. Molecular analysis revealed an increase in type I interferons (IFNα and IFNβ) in the frontal lobe, correlating with these neuronal changes.
The overall branching pattern and distribution of dendrites are important determinants of neuronal function, but the functional effect resulting from this apparent plasticity depends on the exact changes in neuronal connectivity. In this regard, we found that in addition to the decrease in dendrites, the number of dendritic spines, the major sites of synaptic contacts, was also decreased in the middle frontal gyrus. Decreased dendritic branching and spines indicate substantial damage to neurons as a result of chronic METH in primates.
As previously mentioned, high-resolution MRI has revealed significant changes in the cingulate gyrus and hippocampus of human METH abusers (Thompson et al. 2004 ). Our Golgi analysis may be a reflection of such changes in the cingulated; however, we found no evidence for hippocampal changes by Golgi analysis (data not shown).
Molecular analysis revealed an increase in both IFNα and IFNβ in the frontal lobe. These type I IFNs are essential in coping with viral infections in CNS (Haller et al. 2006 ). However, this protective effect can come with a significant price. In vivo studies of transgenic mice producing IFNα chronically from astrocytes have shown that overproduction on IFNα can lead to severe pathology in the brain, including neurodegeneration, calcification of the basal ganglia, progressive inflammatory encephalopathy, and meningoencephalitis (Akwa et al. 1998 ). Although we found that the increased IFN correlates with the neurostructual changes, the mechanisms by which IFN may lead to these changes are not clear.
One of the untoward features of METH abuse is an increased risk for other unhealthy actions. Due to the riskinduced behaviors posed by METH and enhanced sexual pleasure, METH users are more likely to have several sexual partners, leading to higher risk of HIV infection (Gibson et al. 2002) , resulting in a distinct overlap between METH users and the HIV+ population. Interestingly, we had found increased expression of IFN-induced genes in the brains of those with HIV-induced CNS disease who also used METH (Everall et al. 2005) . The increase in IFN we find in the brain following METH administration may be the cause of these findings and indicate a significant interaction of METH and HIV in the CNS. Certainly, our experiment reveals that METH administration results in significant changes in neuronal structure as well as gene expression in the primate CNS.
